KIWA Will Formally Submit Financial Statements To The OTC Markets

News ReleaseBy wp-admin09/28/2021Leave a comment

September 28, 2021 Based on the consensus reached with its restructuring partner, Kiwa Bio-Tech Products Group Corporation (KIWA, or the “Company”) has formally submitted an application to re-activate its account at the OTC Markets, and has paid related fees. The application is currently under the OTC Markets’ review. The Company’s legal counsel also urged the…

The first phase of Kiwa Bio-Tech restructuring was completed and all tasks were fully started and implemented.

News ReleaseBy wp-admin09/13/2021Leave a comment

On September 13, 2021, the Board of Directors of Kiwa Bio-Tech officially announced that the first phase of the company’s restructuring has been completed. Mr. Wade Li, Chairman and CEO, said that Kiwa has re-appointed JLKZ CPA LLP as the company’s auditor, and VCL LAW LLP as the company’s legal counsel. The company has recently…